Skip to content
Events

Details

Illumina will be sponsoring the 91st Annual Congress of the Swiss Society of Pathology (SGPath 2026) in Aarau, Switzerland, from the 12th to the 14th of November.

Come and visit us at booth 7, where you can meet our expert team to learn about our solutions and services on offer and discuss any requirements you may have.

Date & Time
12 Nov 2026 – 14 Nov 2026
Location
KUK Aarau, Schlossplatz 9, Aarau
Switzerland
Europe
Topic
Genetic & rare diseases, Oncology
Visit Website

Related Events

Nov 10
AMP 2026 Annual Meeting and Expo
10 Nov 2026 – 14 Nov 2026
Visit Illumina booth 727 at AMP to discover how we’re helping laboratories advance precision genomics today while preparing for the future of genomic research.
View Event
Nov 11
Unlocking AML biology with 5-base whole-genome sequencing: Integrated genomic and epigenomic profiling for biomarker discovery
11 Nov 2026
5-base WGS can enable deeper biological insights and advance translational research in AML and other hematologic malignancies.
View Event
Nov 11
Expanding precision oncology: Practical strategies for integrating tissue and liquid biopsy comprehensive genomic profiling
11 Nov 2026
Combining tissue and liquid biopsy expands actionable biomarker detection and supports timely, informed treatment decisions.
View Event
For Research Use Only

Not for use in diagnostic procedures.

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.